Oslo Norway, January 24, 2025. The LINK Medical Board is pleased to announce the appointment of Anders Göransson as the new CEO of LINK Medical.
Anders has over 20 years of diverse experience in the life science industry, he has established an impressive track record of success. Anders has held prominent positions at leading biotech companies, top-tier management consulting firms, and as CEO of a publicly listed med-tech company. Anders holds a MBA from Suffolk University’s Sawyer Business School in Boston, and a MSc in International Business from Uppsala.
Most recently, Anders served as CEO of Bactiguard AB, a global med-tech company specializing in infection prevention solutions. Prior to that, he held several international leadership roles at Amgen and has also gained valuable experience at firms such as McKinsey & Company and Ernst Young.
Chairman Michael Bodd states: “We are pleased to welcome Anders as the new CEO of LINK Medical. His diverse experience, combined with his deep industry knowledge and leadership capabilities, positions him well to lead LINK Medical into its next phase of growth and innovation. Under his leadership, we anticipate building on our strengths to drive growth and profitability across our core business areas.
I would also like to extend my heartfelt gratitude to Sissel Lønning Andresen for her leadership as CEO over the past several years. Sissel successfully guided the company through a critical phase and transformation, enhancing our value to customers and positioning LINK Medical for sustained success in the future.”
Anders Göransson states: “I am honored and excited to join LINK Medical as CEO during such a pivotal time. I look forward to collaborating with my new colleagues across all departments to continue building on LINK’s strong reputation for delivering high-quality services to the life sciences industry. Together with the talented team, we will drive the company into its next chapter of growth and innovation.”.